Researchers develop way to simplify production of 18F-alfatide

04/9/2013 | MolecularImaging.net

Researchers have devised a kit that uses a fluoride-aluminum complex to ease the production of 18F-alfatide, an agent that can zero in on active tumors in squamous or adenomatous lung carcinoma. The method presented a yield of 42.1%, compared with 5% to 25% for the standard method, according to the study published in The Journal of Nuclear Medicine. The agent is being considered as an alternative to 18F-FPPRGD2, which was recently approved. "Because of the simplicity of the method, an advantage is that additional studies can be easily performed in a single day," researchers said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN